2 Soaring Stocks Wth More Upside Potential
Although fundamental investing wisdom tells us to "buy low," it may still be worthwhile to purchase shares of top companies…
36,700€
-0,76%
Echtzeit-Aktienkurs Exelixis Inc.
Bid:
Ask:
Nachrichten zur Exelixis Inc. Aktie
2 Top Stocks to Buy With Less Than $100
When investing on a budget, buying fractional shares of top companies is one option. Another is to find stocks with…
Why Exelixis Stock Is Skyrocketing Today
Shares of Exelixis (NASDAQ: EXEL) were skyrocketing 18.5% higher at 11:05 a.m. ET on Wednesday. The huge gain came after…
Exelixis: Q1 Earnings Snapshot
ALAMEDA, Calif. (AP) — ALAMEDA, Calif. (AP) — Exelixis Inc. (EXEL) on Tuesday...…
Biotech Leader Pops After Obliterating Profit Expectations
Exelixis stock jumped late Thursday after the top-notch biotech company easily beat first-quarter profit expectations.…
The Smartest Biotech Stocks to Buy With $50
One of the great things about equity markets is that you dont need a fortune to get started. Though strong…
Exelixis Stock Rises 13.3% Year to Date: Buy, Sell or Hold?
EXEL stock gains on the back of encouraging performance of its lead drug Cabometyx and efforts to improve shareholder value.…
Exelixis: Auf 170 % Gewinnanstieg folgen bahnbrechende Studienergebnisse in der Krebstherapie
Mit fast 10 Mio. Todesfällen pro Jahr ist Krebs eine der häufigsten Todesursachen überhaupt. Deshalb wird in der Medizin aktuell…
Analysts Give The Green Light To Two Stocks With Brighter Outlook Than Even Nvidia
Analysts are bullish on both Carpenter Technology and Exelixis stock. Both are in bases with proper buy points in a…
Exelixis nach starken Zahlen und neuem Aktienrückkaufprogramm vor Ausbruch auf Allzeithoch!
Exelixis überzeugte am 11. Februar mit starken Zahlen zum 4. Quartal, die sowohl beim Umsatz mit 566,8 Mio. USD als…
Why Exelixis Stock Trounced the Market on Thursday
Cancer drug specialist Exelixis (NASDAQ: EXEL) was quite the stock market star on Friday. Following news that its making a…
Exelixis (EXEL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Exelixis (EXEL) give a sense of how the business performed in the quarter…
2 Stocks to Buy With Less Than $40
Some think investing in stocks requires substantial start-up capital, but thats false. Even with a modest sum, like $40, investors…
Exelixis ist mit Cabometyx-Erfolg ein Top-Breakout-Kandidat unter den Biotech-Stocks!
Mehrere Biotechfirmen überraschen gerade mit ihren vorläufigen Quartalsergebnissen. Hier zählt nun auch Exelixis (EXEL) nach dem bereits erfolgreichen Big-Picture-Breakout zu…
Brookline Capital sets $40 target on Exelixis stock with Buy rating By Investing.com
Brookline Capital sets $40 target on Exelixis stock with Buy rating…
2 Biotech Stocks to Buy Hand Over Fist in December
The biotech industry has lagged the broader market so far in 2024. The SPDR S&P Biotech ETF, an industry benchmark,…
Exelixis nutzt Tyrosinkinase-Inhibitoren zur Krebsbehandlung - Zanzalintinib liefert eine zusätzliche 5 Mrd. USD-Umsatzchance bis 2033!
Das Biotechunternehmen Exelixis (EXEL) hat sich auf Tyrosinkinase-Inhibitoren zur Krebsbehandlung spezialisiert. Diese können Enzyme blockieren und damit das Tumorwachstum sowie…
End of Year Rally: 3 Stocks to Watch (IDCC, FUTU, EXEL)
InterDigital, Futu Holdings and Exelixis are all stocks with reasonable valuations and bullish catalysts…
Nach einer Prognoseanhebung und einem Up-Gap könnte die Aktie von Exelixis nun das Allzeithoch in Angriff nehmen!
Über Exelixis habe ich das letzte Mal nach den starken Q2-Zahlen im Juli berichtet. Die Aktie konnte in den letzten…
Exelixis, Inc. 2024 Q3 - Results - Earnings Call Presentation
…
Exelixis, Inc. (EXEL) Q3 2024 Earnings Call Transcript
…
Zacks.com featured highlights Genpact, MPLX, Exelixis, Paramount Global and H&R Block
Genpact, MPLX, Exelixis, Paramount Global and H&R Block have been highlighted in this Screen of The Week article.…
5 Top-Ranked Value Stocks With Discounted PEG Ratio to Buy
Five PEG-based stocks that fulfill our screening criteria are Genpact, MPLX, Exelixis, Paramount Global and H&R Block.…
Exelixis, Inc. (EXEL) Q2 2024 Earnings Call Transcript
…
Ipsen expands collaboration agreement with Exelixis
…
Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript
…
Exelixis, Inc.s (NASDAQ:EXEL) Financials Are Too Obscure To Link With Current Share Price Momentum: Whats In Store For the Stock?
Exelixis (NASDAQ:EXEL) has had a great run on the share market with its stock up by a significant 5.1% over…
Exelixis director Garber Alan M sells shares worth over $460k By Investing.com
Exelixis director Garber Alan M sells shares worth over $460k…